Skip to main content
An official website of the United States government
Principal Investigator
Michael E. Roth
Awardee Organization

Public Health Institute
United States

Fiscal Year
2025
Activity Code
UG1
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant

The prognosis for children with cancer has improved dramatically over the past decades with an overall 5-year survival rate now at 86%. However, the late effects of cancer treatment, including permanent organ and tissue damage, hormonal and reproductive dysfunction and second cancers, are of special concern, with more than 40% of the estimated 500,000 survivors of childhood cancer experiencing a significant health-related quality of life complication from childhood cancer and its treatment. In addition, progress for a number of childhood cancers remains limited with approximately 50% of children with acute myelogenous leukemia, 50% of children with high-risk neuroblastoma, and more than 90% of children with brainstem glioma, still succumbing to their disease. The Children’s Oncology Group (COG), the world’s largest organization devoted exclusively to childhood and adolescent cancer research, and its multidisciplinary research teams comprised of more than 9,000 members, conducts research at more than 220 leading children’s hospitals, universities, and cancer centers. This proposal seeks to continue the COG NCI Community Oncology Research Program (NCORP) Research Base in its collaborative work with 47 sites. With COG’s significant scientific, statistical, data management and information technology infrastructure, we seek to conduct pediatric clinical trials to define optimal treatments, and conduct laboratory research that will translate into more effective treatments with reduced side effects. The COG directly addresses the NCORP goals of providing access to state-of-the-art cancer treatment at community sites while conducting research in cancer control, including post-treatment surveillance/survivorship, and cancer care delivery. We promote the participation of community-based investigators in all of COG’s research, governance and administration and in NCORP Network activities. The COG’s research goals are to reduce overall mortality and morbidity, decrease acute and delayed treatment-related toxicities, and develop more effective ways of delivering care to children, adolescents and young adults. The COG NCORP Research Base is uniquely positioned to elucidate the impact of different health care delivery characteristics on outcomes, to identify determinants of poorer outcomes in children, adolescents, and young adults, and to develop targeted strategies aimed at improving efficiencies for the delivery of cancer care in children and young adults with cancer.

Publications

  • Mittal N, Langevin AM, Kyono W, Dickens DS, Grimes A, Salsman JM, Pollock BH, Roth M. Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial. Journal of adolescent and young adult oncology. 2022 Feb;11(1):117-121. Epub 2021 May 13. PMID: 33983848

Clinical Trials

Study Name Clinical Trial ID
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia NCT07022678
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study NCT06410209
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer NCT03223753
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy NCT01503086
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment NCT01790152
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma NCT03057626
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant NCT03057054
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission NCT01503632
Neuropsychological and Behavioral Testing in Younger Patients With Cancer NCT00772200
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma NCT05602194
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant NCT01503515
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant NCT01817075
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies NCT00736749
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia NCT01307579
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer NCT05228275
Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study NCT04089358
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma NCT05705531
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors NCT02717507
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor NCT04939597
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients NCT05711667
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors NCT03206450
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas NCT01793233
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors NCT00082745
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States NCT04928599
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology NCT02847130
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia NCT03204916
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia NCT05702645
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer NCT06513962
A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home NCT06639958